(21 days)
Not Found
No
The summary describes a physical catheter device with antimicrobial properties, and there is no mention of AI, ML, or any software-based analysis or processing.
Yes
The device is used for draining cerebrospinal fluid to reduce intracranial pressure and CSF volume, which is a therapeutic intervention.
No
The device is described as a catheter set intended for draining cerebrospinal fluid to reduce intracranial pressure and CSF volume. Its function is therapeutic, not diagnostic.
No
The device description clearly states it is a physical catheter set made of silicone and impregnated with antimicrobials, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to gain access to the ventricles of the brain for draining cerebrospinal fluid and other fluids. This is a surgical/interventional procedure performed directly on the patient's body.
- Device Description: The device is a catheter designed for insertion into the brain. It is a physical tool used for drainage.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens in vitro (outside the body) to provide information about a physiological state, health, or disease. IVDs typically involve tests on samples like blood, urine, or tissue.
Therefore, the Codman® BACTISEAL® EVD Catheter Set and Codman® BACTISEAL® Clear EVD Catheter Set are medical devices used for a surgical procedure, not for in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
The CODMAN® BACTISEAL EVD Catheter Sets and CODMAN® BACTISEAL® Clear EVD Catheter Set are indicated for gaining access to the ventricles of the brain and can be used with dimensionally compatible devices for draining cerebrospinal fluid (CSF) and other fluids of similar physical characteristics as a means of reducing intracranial pressure and CSF volume.
Product codes
JXG
Device Description
The CODMAN® BACTISEAL® EVD Catheter Set and CODMAN® BACTISEAL® Clear EVD Catheter Set are 1.9 mm inner diameter ventricular catheters packaged with components to facilitate placement and use of the ventricular catheter. Both products are subjected to a treatment process by which the silicone is impregnated with two antimicrobials, rifampicin and clindamycin hydrochloride. Bactiseal silicone catheters have been shown in laboratory studies to reduce the colonization of gram positive bacteria on the tubing surface.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
ventricles of the brain
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Bench testing has been completed and demonstrates that the device performs according to its description and intended use which is the same as the predicate device. All test results demonstrated the substantial equivalence of the product to the commercially distributed devices for the same intended use.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.5550 Central nervous system fluid shunt and components.
(a)
Identification. A central nervous system fluid shunt is a device or combination of devices used to divert fluid from the brain or other part of the central nervous system to an internal delivery site or an external receptacle for the purpose of relieving elevated intracranial pressure or fluid volume (e.g., due to hydrocephalus). Components of a central nervous system shunt include catheters, valved catheters, valves, connectors, and other accessory components intended to facilitate use of the shunt or evaluation of a patient with a shunt.(b)
Classification. Class II (performance standards).
0
11090348
510(k) Summary
:
A. Submitter Information
·
| Submitter's name: Address: | Codman & Shurtleff, Inc. 325 Paramount Drive Raynham, MA 02767 | MAR. - 4. 2009 |
|---|---|---|
| Telephone: | 508-880-8349 | |
| Fax: | 508-828-2777 | |
| Contact Person: | Sharon McDermott | |
| Date of Submission: | February 10, 2009 | |
| B. Trade/Device Name: | CODMAN ® BACTISEAL® EVD Catheter Set | |
| CODMAN ® BACTISEAL® Clear EVD Catheter Set | ||
| Common Name: | Ventricular catheters | |
| Classification Name: | Central Nervous System Fluid Shunt and Components | |
| Regulatory Class: | Class II per 21 CFR § 882.5550 | |
| Product Code: | JXG | |
| C. Predicate Device: | CODMAN® BACTISEAL® EVD Catheter Sets (K021653) | |
| CODMAN® BACTISEAL® Barium Striped Catheters (K031123) | ||
| D. Device Description: | The CODMAN® BACTISEAL® EVD Catheter Set and CODMAN® BACTISEAL® Clear EVD Catheter Set are 1.9 mm inner diameter ventricular catheters packaged with components to facilitate placement and use of the ventricular catheter. Both products are subjected to a treatment process by which the silicone is impregnated with two antimicrobials, rifampicin and clindamycin hydrochloride. Bactiseal silicone catheters have been shown in laboratory studies to reduce the colonization of gram positive bacteria on the tubing surface. | |
| E. Intended Use: | The CODMAN® BACTISEAL EVD Catheter Sets and CODMAN® BACTISEAL® Clear EVD Catheter Set are indicated for gaining access to the ventricles of the brain and can be used with dimensionally compatible devices for draining cerebrospinal fluid (CSF) and other fluids of similar physical characteristics as a means of reducing intracranial pressure and CSF volume |
. . . .
1
- F. Summary of technological characteristics of the proposed to the predicate device. The technological characteristics of the proposed device are the exact same as the predicate device.
G. Performance Data
Bench testing has been completed and demonstrates that the device performs according to its description and intended use which is the same as the predicate device. All test results demonstrated the substantial equivalence of the product to the commercially distributed devices for the same intended use.
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" arranged around the perimeter. Inside the circle is a stylized symbol resembling an abstract eagle or bird in flight, composed of three curved lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Codman and Shurtleff, Inc. c/o Ms. Sharon McDermott Regulatory Affairs Associate II 325 Paramount Drive Raynham, MA 02767
MAR - 4 2009
Re: K090348
Trade/Device Name: Codman® Bactiseal® EVD Catheter Set and Codman® Bactiseal® Clear EVD Catheter Set Regulation Number: 21 CFR 882.5550
Regulation Name: Central nervous system fluid shunt and components Regulatory Class: Class II Product Code: JXG Dated: February 10, 2009 Received: February 11, 2009
Dear Ms. McDermott:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
M. B. Eggleston, m.D.
Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
1096348 510(k) Number (if known):
Device Name:
Codman® BACTISEAL® EVD Catheter Set and Codman® BACTISEAL® Clear EVD Catheter Set
Indications For Use:
Codman® BACTISEAL® EVD Catheter Set and Codman® BACTISEAL® Clear EVD Catheter Set are indicated for gaining access to the ventricles of the brain and can be used with dimensionally compatible devices for draining cerebrospinal fluid (CSF) and other fluids of similar physical characteristics as a means of reducing intracranial pressure and CSF volume.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Division Sign-Off) Division of Ophthalmic and Ear, Nose and Throat Devices
510(k) Number K090348
10